- Exchange: Copenhagen
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Novozymes A/S (NZYMB)
| Open: | 202.000 | Day's Range: | 199.700 - 202.200 | Volume: | 381,529 |
|---|---|---|---|---|---|
| Previous Close: | 201.800 | 52wk Range: | 144.400 - 208.600 | 1-Yr Rtn: | +31.98% |
Key Statistics for NZYMB
| Current P/E Ratio (ttm) | 31.3138 |
|---|---|
| Estimated P/E(12/2013) | 28.9112 |
| Relative P/E vs. KFX | 1.4289 |
| Earnings Per Share (DKK) (ttm) | 6.4444 |
| Est. EPS (DKK) (12/2013) | 6.9800 |
| Est. PEG Ratio | 3.3231 |
| Market Cap (M DKK) | 64,515.46 |
| Shares Outstanding (M) | 265.96 |
| 30 Day Average Volume | 371,274 |
| Price/Book (mrq) | 5.5686 |
| Price/Sale (ttm) | 5.5729 |
| Dividend Indicated Gross Yield | 1.09% |
| Cash Dividend (DKK) | 2.2000 |
| Last Dividend | 03/01/2013 |
| 5 Year Dividend Growth | 17.08% |
| Next Earnings Announcement | 08/16/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NZYMB
Company Profile & Key Executives for NZYMB
Novozymes A/S is a biotechnology based company. The Company researches, develops, produces, and sells enzymes for industrial use. Novozymes works within three main segments: the technical enzyme market, the food enzyme market, and the animal feed enzyme market. The Company has a worldwide distribution network, as well as operates sales and service centers online.
| Henrik GuertlerChairman | Kurt Anker NielsenVice Chairman |
| Peder Holk NielsenPresident/CEO | Benny D LoftExec VP:Corporate Functions/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NZYMB News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page